Care and Quality Improvement Approaches, from the Chief of Cardiovascular Medicine at Stanford University School of Medicine
September 10th, 2024
Eldrin F. Lewis
Dr. Lewis is the Simon H. Stertzer, MD Professor of Medicine and Chief of Cardiovascular Medicine at Stanford University School of Medicine. Over the past 4 ½ years as Chief of Cardiovascular Medicine, he has expanded the clinical reach of the division to both the East Bay and South Bay, expanded the faculty to 105, increased the diversity of the faculty and trainees, and expanded the clinical research and clinical trial capacity to dovetail with the existing basic and translational research. He has an interest in preventing the development of and progression of heart failure by investigating novel strategies and therapies for treating early heart failure and co-morbid illnesses that are risk factors for heart failure. He performs quality-of-life research to better understand how to improve these outcomes and include them into medical decision-making. As an advanced heart disease specialist, he specializes in the management of patients with advanced heart failure, heart transplantation, and those with mechanical circulatory support devices. His work has included understanding the biological and social factors that influence patient-reported outcomes and progression of disease from risk factors (e.g., diabetes, chronic kidney disease, and hypertension) to heart failure with approximately 250 publications. He is leading an effort to understand how to enhance the diversity of participants in clinical trials and is on numerous steering committees. He holds numerous leadership positions in national organizations, including Chair of the Scientific Publishing Committee for the American Heart Association (AHA), President of the AHA Board of Directors for the Western States, and Chair of the Research Committee for the Association of Black Cardiologists.
